id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0811-0153,FDA,FDA-2013-D-0811,Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat Clostridioides difficile Infection Not Responsive to Standard Therapies; Guidance for Industry; Availability,Notice,Notice of Availability,2022-11-29T05:00:00Z,2022,11,2022-11-29T05:00:00Z,,2022-11-29T15:13:37Z,2022-26000,0,0,0900006485507229
FDA-2013-D-0811-0154,FDA,FDA-2013-D-0811,Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridioides difficile Infection Not Responsive to Standard Therapies,Other,Guidance,2022-11-29T05:00:00Z,2022,11,2022-11-29T05:00:00Z,,2024-11-12T23:47:21Z,,1,0,09000064855086d2
FDA-2013-D-0811-0070,FDA,FDA-2013-D-0811,"Attachment 2 Roman, M. Micro-Biome Restorative Therapy: Successful treatment of Dogs and Cats with Fecal Transplants  re: Comment from Margo Roman",Supporting & Related Material,Background Material,2016-04-25T04:00:00Z,2016,4,,,2016-04-25T14:21:54Z,,0,0,0900006481f896a1
FDA-2013-D-0811-0023,FDA,FDA-2013-D-0811,Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies; Draft Guidance for Industry,Other,Guidance,2016-03-01T05:00:00Z,2016,3,2016-03-01T05:00:00Z,,2022-11-29T15:22:54Z,,0,0,0900006481e94ffc
FDA-2013-D-0811-0022,FDA,FDA-2013-D-0811,Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat Clostridium difficile Infection Not Responsive to Standard Therapies; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2016-03-01T05:00:00Z,2016,3,2016-03-01T05:00:00Z,2016-06-01T03:59:59Z,2016-06-01T13:00:28Z,2016-04372,0,0,0900006481e95288
FDA-2013-D-0811-0004,FDA,FDA-2013-D-0811,Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat Clostridium difficile Infection Not Responsive to Standard Therapies,Other,Guidance,2014-02-26T05:00:00Z,2014,2,2014-02-26T05:00:00Z,,2024-11-12T05:25:14Z,,1,0,09000064815c494a
FDA-2013-D-0811-0003,FDA,FDA-2013-D-0811,Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat Clostridium difficile Infection Not Responsive to Standard Therapies; Availability,Notice,Notice of Availability,2014-02-26T05:00:00Z,2014,2,2014-02-26T05:00:00Z,2014-03-29T03:59:59Z,2014-03-30T02:51:42Z,2014-04095,0,0,09000064815c3a1e
FDA-2013-D-0811-0001,FDA,FDA-2013-D-0811,Guidance for Industry; Availability: Enforcement Policy Regarding Investigational New Drug Requirements; Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies,Notice,,2013-07-18T04:00:00Z,2013,7,2013-07-18T04:00:00Z,,2013-07-18T14:21:00Z,2013-17223,0,0,090000648136d493
FDA-2013-D-0811-0002,FDA,FDA-2013-D-0811,Guidance for Industry; Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies,Other,Guidance,2013-07-01T04:00:00Z,2013,7,2013-07-01T04:00:00Z,,2024-11-07T22:54:24Z,,1,0,090000648136d20e